Epilepsy Talk Radio

Dr. Joseph Sirven of Epilepsy.com interviews Dr. Andrew Wilner, epileptologist, author and jounalist on his latest research on how to manage the comorbidities ( depression, anxiety, memory problems) that are often linked to epilepsy.

Dr. Joseph Sirven interviews Dr. James Cloyd on Seizure Emergency Treatment, focusing on Benzodiazepine Prodrug/Enzyme Combinations for Intranasal Rescue Therapies.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Alan B. Ettinger MD, MBA, Professor of Clinical Neurology, Albert Einstein College of Medicine; Epilepsy Director, NSPC Director of EEG, Huntington Hospital; Director of the Epilepsy Wellness Program, Neuroscience Institute at Winthrop University Hospital; Attending Epileptologist, Comprehensive Epilepsy Center of Long Island at St. Charles Hospital about epilepsy and ADHD in adults.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Patricia Dean, ARNP, MSN, from the Brain Institute at Miami Childrens Hospital, and Sandra Cushner Weinstein, PT, LICSW, LCSW-C, Director of Services and Camps, Department of Neurology, at George Washington University School of Medicine. With summer rapidly approaching, they will be talking about Epilepsy Camps. After the interview, you can find out more on the Brainy Camps webpage (www.brainycamps.com) and on the epilepsy.com summer camp section (www.epilepsy.com/get-help/managing-your-epilepsy/summer-camp).

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Steve Kanes, MD, PhD, Chief Medical Officer at SAGE Therapeutics about the SAGE 547 Trial in Status Epilepticus. SAGE-547 is currently being evaluated in a Phase 1/2 clinical trial for super-refractory status epilepticus (SRSE). SAGE-547 demonstrated robust findings in preclinical models of SE, including significantly increased efficacy over current standard-of-care benzodiazepine treatment, and compelling early human experience data. After the interview, you can learn more about refractory epilepsy at: http://www.epilepsy.com/learn/refractory-epilepsy.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Julian Bailes, MD, co-Director of the NorthShore University HealthSystem Neurological Institute based in Evanston, IL. They are talking about one of the latest innovations in treating epilepsy, the minimally-invasive surgery, Visualase. The Visualase System is an MRI-guided laser system for minimally invasive surgery. Visualase, Inc. was awarded a New Therapy Grant from the Epilepsy Foundation/Epilepsy Therapy Project in December 2010.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews John Hixson, MD about the Policy for Optimal Epilepsy Management (POEM) study. The overall goal of the study is to improve the self-management practices of U.S. Veterans with epilepsy such as tracking seizures, managing medications and side effects, and engaging with other people with similar concerns about their condition. The results of the study were presented at the 66th Annual Meeting of the American Academy of Neurology.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Andrew Wilner, MD about international epilepsy clinics

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Dr. Paul Ciechanowski and Naomi Chaytor from University of Washington about PEARLS community-based depression treatment program for adults with epilepsy and comorbid depression.

In this episode of Epilepsy.coms Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Andrew Wilner, MD, FAAN, FRACP, about other problems associated with epilepsy, such as memory loss and depression

In this episode of Epilepsy.coms Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Amy Crepeau, MD, about longterm use of continuous EEG in the hospital.

In this episode of Epilepsy.coms Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Julie Thompson-Dobkin, DO, about Hidden Truths, the Mind Unraveled: Art of Epilepsy

In this episode of Epilepsy.coms Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Selim Benbadis, about the newly approved Aptiom (eslicarbazepine acetate).

This episode of Epilepsy.com Reports includes an exclusive interview with Frank Fischer, the CEO of Neuropace, talking about the newly approved Responsive Neurostimulation System (RNS). Learn more about the RNS

In this episode of Epilepsy.coms Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews David Tolleson, Executive Director of the National Down Syndrome Congress, about Down syndrome and epilepsy.